Dibutyryl cyclic AMP modulates keratinocyte migration without alteration of integrin expression.
Cyclic adenosine monophosphate (cAMP) has long been regarded as a second messenger and a regulator of human keratinocyte proliferation. It has been demonstrated that cAMP inhibits keratinocyte proliferation when used at high concentrations. Nevertheless, new recent reports have demonstrated that cAMP may stimulate or inhibit keratinocyte growth depending upon the concentration used. Studies to examine the influence of cAMP upon the migration of other cell types have been contradictory. To determine the direct effect of dibutyryl cAMP (DBcAMP) upon human keratinocyte migration, we used a quantitative locomotion assay using a wide range of DBcAMP concentrations. We found a bi-phasic effect of DBcAMP on keratinocyte migration across connective tissue matrices. Keratinocyte locomotion on the matrices was promoted at 10(-5) M and 10(-6) M of DBcAMP, but not at higher or lower concentrations. Time-course experiments demonstrated that the effect of DBcAMP on keratinocyte locomotion and proliferation occurred independently. Fluorescence-activated cell sorter analysis demonstrated that the effect of DBcAMP on the migration of human keratinocytes was independent from the modulation of integrin receptors. Although the cellular mechanisms by which DBcAMP promotes keratinocyte migration is unclear, the addition of DBcAMP or TPA to keratinocyte cultures enhanced the synthesis of a 92-kDa metalloproteinase in association with enhanced cellular migration. These observations suggest a possible link between metalloproteinase expression and cellular migration.
Iwasaki
T
T
Department of Dermatology, Stanford University School of Medicine, California.
Chen
J D
JD
Kim
J P
JP
Wynn
K C
KC
Woodley
D T
DT
D003994:Bucladesine / Q000494:pharmacology*; D002455:Cell Division / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D003094:Collagen; D017364:Collagenases / Q000032:analysis / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry; D006023:Glycoproteins; D006801:Humans; D016023:Integrins / Q000032:analysis / Q000502:physiology*; D015603:Keratinocytes / Q000737:chemistry / Q000166:cytology* / Q000502:physiology*; D008297:Male; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors
D006023:Glycoproteins; D016023:Integrins; D003994:Bucladesine; D003094:Collagen; D017364:Collagenases; D013755:Tetradecanoylphorbol Acetate